Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients

被引：6

作者：

Maechler, Melanie ^{[1
]}

Bacher, Ulrike ^{[2
]}

Daskalakis, Michael ^{[2
]}

Nilius, Henning ^{[3
]}

Nagler, Michael ^{[2
]}

Taleghani, Behrouz Mansouri ^{[2
]}

Jeker, Barbara ^{[1
]}

Pabst, Thomas ^{[1
]}

机构：

[1] Univ Bern, Univ Hosp Bern, Dept Med Oncol, CH-3010 Bern, Switzerland

[2] Univ Bern, Univ Hosp Bern, Dept Hematol & Cent Hematol Lab, Bern, Switzerland

[3] Univ Bern, Univ Hosp Bern, Univ Inst Clin Chem, Inselspital, Bern, Switzerland

来源：

HEMATOLOGICAL ONCOLOGY | 2023年 / 41卷 / 03期

关键词：

autologous stem cell transplantation (ASCT); long-term safety; multiple myeloma; plerixafor; stem cell mobilization; COLONY-STIMULATING FACTOR; MULTIPLE-MYELOMA; MOBILIZATION; VINORELBINE; TRANSPLANTATION; CHEMOTHERAPY; GUIDELINES;

D O I：

10.1002/hon.3055

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：583 / 586

页数：4

共 14 条

[1]

Alvarnas JC, 2004, ONCOLOGY-NY, V18, P867

[2] Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective [J].

Bargetzi, MJ ;

Passweg, J ;

Baertschi, E ;

Schoenenberger, A ;

Gwerder, C ;

Tichelli, A ;

Burger, J ;

Mingrone, W ;

Herrmann, R ;

Gratwohl, A ;

Wernli, M .

BONE MARROW TRANSPLANTATION, 2003, 31 (02) :99-103

[3] Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma [J].

DiPersio, John F. ;

Stadtmauer, Edward A. ;

Nademanee, Auayporn ;

Micallef, Ivana N. M. ;

Stiff, Patrick J. ;

Kaufman, Jonathan L. ;

Maziarz, Richard T. ;

Hosing, Chitra ;

Frueehauf, Stefan ;

Horwitz, Mitchell ;

Cooper, Dennis ;

Bridger, Gary ;

Calandra, Gary .

BLOOD, 2009, 113 (23) :5720-5726

[4] Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization [J].

Dugan, M. J. ;

Maziarz, R. T. ;

Bensinger, W. I. ;

Nademanee, A. ;

Liesveld, J. ;

Badel, K. ;

Dehner, C. ;

Gibney, C. ;

Bridger, G. ;

Calandra, G. .

BONE MARROW TRANSPLANTATION, 2010, 45 (01) :39-47

[5] International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100) [J].

Giralt, S. ;

Stadtmauer, E. A. ;

Harousseau, J. L. ;

Palumbo, A. ;

Bensinger, W. ;

Comenzo, R. L. ;

Kumar, S. ;

Munshi, N. C. ;

Dispenzieri, A. ;

Kyle, R. ;

Merlini, G. ;

San Miguel, J. ;

Ludwig, H. ;

Hajek, R. ;

Jagannath, S. ;

Blade, J. ;

Lonial, S. ;

Dimopoulos, M. A. ;

Einsele, H. ;

Barlogie, B. ;

Anderson, K. C. ;

Gertz, M. ;

Attal, M. ;

Tosi, P. ;

Sonneveld, P. ;

Boccadoro, M. ;

Morgan, G. ;

Sezer, O. ;

Mateos, M. V. ;

Cavo, M. ;

Joshua, D. ;

Turesson, I. ;

Chen, W. ;

Shimizu, K. ;

Powles, R. ;

Richardson, P. G. ;

Niesvizky, R. ;

Rajkumar, S. V. ;

Durie, B. G. M. .

LEUKEMIA, 2009, 23 (10) :1904-1912

[6] A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients [J].

Jeker, Barbara ;

Farag, Sarah ;

Taleghani, Behrouz Mansouri ;

Novak, Urban ;

Mueller, Beatrice U. ;

Li, Qiyu ;

Betticher, Daniel ;

Luethi, Jean-Marc ;

Farese, Simone ;

Ruefer, Axel ;

Bacher, Ulrike ;

Pabst, Thomas .

BONE MARROW TRANSPLANTATION, 2020, 55 (10) :2047-2051

[7] Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment [J].

Keller, Sandra ;

Seipel, Katja ;

Novak, Urban ;

Mueller, Beatrice U. ;

Taleghani, Behrouz Mansouri ;

Leibundgut, Kurt ;

Pabst, Thomas .

LEUKEMIA RESEARCH, 2015, 39 (07) :786-792

[8] Multiple Myeloma, Version 3.2017 Clinical Practice Guidelines in Oncology [J].

Kumar, Shaji K. ;

Callander, Natalie S. ;

Alsina, Melissa ;

Atanackovic, Djordje ;

Biermann, J. Sybil ;

Chandler, Jason C. ;

Costello, Caitlin ;

Faiman, Matthew ;

Fung, Henry C. ;

Gasparetto, Cristina ;

Godby, Kelly ;

Hofmeister, Craig ;

Holmberg, Leona ;

Holstein, Sarah ;

Huff, Carol Ann ;

Kassim, Adetola ;

Liedtke, Michaela ;

Martin, Thomas ;

Omel, James ;

Raje, Noopur ;

Reu, Frederic J. ;

Singhal, Seema ;

Somlo, George ;

Stockerl-Goldstein, Keith ;

Treon, Steven P. ;

Weber, Donna ;

Yahalom, Joachim ;

Shead, Dorothy A. ;

Kumar, Rashmi .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (02) :230-+

[9] Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report [J].

Micallef, Ivana N. ;

Stiff, Patrick J. ;

Nademanee, Auayporn P. ;

Maziarz, Richard T. ;

Horwitz, Mitchell E. ;

Stadtmauer, Edward A. ;

Kaufman, Jonathan L. ;

McCarty, John M. ;

Vargo, Rita ;

Cheverton, Peter D. ;

Struijs, Martin ;

Bolwell, Brian ;

DiPersio, John F. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (06) :1187-1195

[10] Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor [J].

Morris, Curly ;

Chabannon, Christian ;

Masszi, Tamas ;

Russell, Nigel ;

Nahi, Hareth ;

Kobbe, Guido ;

Krejci, Marta ;

Auner, Holger W. ;

Pohlreich, David ;

Hayden, Patrick ;

Basak, Grzegorz W. ;

Lenhoff, Stig ;

Schaap, Nicolaas ;

van Biezen, Anja ;

Knol, Cora ;

Iacobelli, Simona ;

Liu, Qianying ;

Celanovic, Marina ;

Garderet, Laurent ;

Kroeger, Nicolaus .

BONE MARROW TRANSPLANTATION, 2020, 55 (02) :356-366

← 1 2 →